Biotech Veteran Peter Olagunju Joins ImmunoScape As CEO

KUALA LUMPUR, Sept 24 (Bernama) -- ImmunoScape Pte Ltd, an A*STAR spin-out developing T-cell receptor (TCR)-based cancer immunotherapies, has appointed biotechnology industry veteran Peter Olagunju as chief executive officer (CEO) to guide its "Seed and Boost" platform towards clinical development.